C. Marzolini

Discipline

Sociologie (2) Economies et finances (1) Anthropologie biologique (1)

Type de document

Articles (35) Recensions (8)

Co-auteur

Date

Source

Mot-clé

Human beings (29) Treatment (25) Drugs (16) Older people (16) Patients (15) Patients (15) thérapie (14) Therapeutics (14) Use (14) pharmacocinétique (13) Pharmacokinetics (13) Pharmacokinetics (13) Management (12) risque (11) exposition (11) adulte (11) Risk (11) adulte (11) Persons (10) Antiretroviral agents (10) cohorte (10) effet (9) Drug interactions (9) modèle (8) Methods (8) Swiss (8) Population (8) Manufacturers' agents (8) Example (8) Commission merchants (8)

Documents écrit par C. Marzolini (35) | parle de C. Marzolini (0)

Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
J. Ambrosioni et al.
Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers
M. Berton et al.
What is the significance of the pharmacokinetic profile and potential drug-drug interactions of long-acting intramuscular cabotegravir and rilpivirine?
S. Bettonte et al. (2023)
Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study.
K. Aebi-Popp et al. (28 nov. 2022)
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
P. Thoueille et al. (29 juil. 2022)
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions
C. Marzolini et al.
Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients
F. Stader et al.
Magnitude of Drug-Drug Interactions in Special Populations
S. Bettonte et al. (2022)
Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir
F. Stader et al.
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.
P. Courlet et al.
Physiologically-Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV.
F. Stader et al.
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV.
S. Alves Saldanha et al.
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment
F. Marra et al.
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19
C. Marzolini et al.
Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance
A. Mari et al. (2021)
COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions
D. Back et al.
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV.
P. Courlet et al.
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
P. Courlet et al.
The challenge of HIV treatment in an era of polypharmacy
D. Back et al.
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
C. Marzolini et al. (2020)
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
D. Hodge et al. (2020)
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect
F. Stader et al. (2020)
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
P. Courlet et al.
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.
Y. Ruffieux et al.
Prescribing issues in older adults living with HIV: thinking beyond drug-drug interactions with antiretroviral drugs.
F. Livio et al. (2019)

next